- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 317/30 - Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 317/30
Total number of patents in this class: 132
10-year publication summary
|
13
|
7
|
13
|
2
|
0
|
4
|
11
|
4
|
10
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alnylam Pharmaceuticals, Inc. | 1140 |
19 |
| Gfbiochemicals Limited | 50 |
10 |
| Gilead Sciences, Inc. | 2106 |
5 |
| Centre National de La Recherche Scientifique | 10706 |
4 |
| Ambrx, Inc. | 175 |
4 |
| Bayer Cropscience AG | 1983 |
3 |
| FUJIFILM Corporation | 29839 |
3 |
| President and Fellows of Harvard College | 6043 |
3 |
| JSR Corporation | 2542 |
3 |
| Okinawa Institute of Science and Technology School Corporation | 161 |
3 |
| Segetis, Inc. | 38 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 869 |
3 |
| Toyama Chemical Co., Ltd. | 99 |
3 |
| Endothelium Scanning Nanotechnology Limited | 6 |
3 |
| Dow AgroSciences LLC | 1214 |
2 |
| National University Corporation Okayama University | 458 |
2 |
| Sekisui Medical Co., Ltd. | 669 |
2 |
| The University of Montana | 100 |
2 |
| University of Washington through its Center for Commercialization | 507 |
2 |
| Laurus Labs Limited | 100 |
2 |
| Other owners | 51 |